J Gynecol Oncol.  2010 Jun;21(2):133-133. 10.3802/jgo.2010.21.2.133.

In reply: Tumor-associated lymphocytes expanded ex vivo from malignant ascites

• Lee SW
• Kim YM

• KMID: 2009586
• DOI: http://doi.org/10.3802/jgo.2010.21.2.133

Abstract

No abstract available.

MeSH Terms

Ascites
Lymphocytes

Reference

1. Beyer M, Kochanek M, Darabi K, Popov A, Jensen M, Endl E, et al. Reduced frequencies and suppressive function of CD4+ CD25high regulatory T cells in patients with chronic lymphocytic leukemia after therapy with fludarabine. Blood. 2005. 106:2018–2025.

2. Aruga T, Suzuki E, Saji S, Horiguchi S, Horiguchi K, Sekine S, et al. A low number of tumor-infiltrating FOXP3-positive cells during primary systemic chemotherapy correlates with favorable anti-tumor response in patients with breast cancer. Oncol Rep. 2009. 22:273–278.

3. Correale P, Rotundo MS, Del Vecchio MT, Remondo C, Migali C, Ginanneschi C, et al. Regulatory (FoxP3+) T-cell tumor infiltration is a favorable prognostic factor in advanced colon cancer patients undergoing chemo or chemoimmunotherapy. J Immunother. 2010. 33:435–441.

4. Shimizu K, Nakata M, Hirami Y, Yukawa T, Maeda A, Tanemoto K. Tumor-infiltrating Foxp3+ regulatory T cells are correlated with cyclooxygenase-2 expression and are associated with recurrence in resected non-small cell lung cancer. J Thorac Oncol. 2010. 5:585–590.